Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 8 | 2023 | 470 | 2.200 |
Why?
|
| Sequence Analysis, RNA | 5 | 2023 | 651 | 1.810 |
Why?
|
| RNA | 3 | 2023 | 1013 | 1.510 |
Why?
|
| Gene Expression Profiling | 7 | 2023 | 5159 | 1.390 |
Why?
|
| Transcriptome | 7 | 2024 | 1859 | 1.000 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 855 | 0.980 |
Why?
|
| Connectome | 1 | 2024 | 112 | 0.830 |
Why?
|
| Cellular Senescence | 1 | 2021 | 382 | 0.670 |
Why?
|
| Synapses | 1 | 2023 | 509 | 0.660 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 363 | 0.550 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2012 | 78 | 0.550 |
Why?
|
| Lysogeny | 2 | 2010 | 10 | 0.490 |
Why?
|
| Synaptosomes | 2 | 2024 | 37 | 0.460 |
Why?
|
| Macrophages | 2 | 2019 | 1304 | 0.430 |
Why?
|
| Hair Cells, Auditory | 2 | 2024 | 60 | 0.410 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2010 | 64 | 0.380 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 2291 | 0.380 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1724 | 0.360 |
Why?
|
| Point Mutation | 1 | 2012 | 769 | 0.360 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 192 | 0.350 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2021 | 107 | 0.340 |
Why?
|
| Transcription Factors | 3 | 2024 | 5270 | 0.330 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 4821 | 0.310 |
Why?
|
| Genomic Instability | 1 | 2010 | 519 | 0.310 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 1910 | 0.290 |
Why?
|
| Glioblastoma | 1 | 2017 | 1797 | 0.290 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1516 | 0.270 |
Why?
|
| Genomics | 1 | 2017 | 2738 | 0.270 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 622 | 0.250 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5061 | 0.230 |
Why?
|
| Genome, Human | 3 | 2021 | 1869 | 0.230 |
Why?
|
| Deafness | 1 | 2024 | 82 | 0.230 |
Why?
|
| Repressor Proteins | 1 | 2010 | 1664 | 0.220 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 2864 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 1547 | 0.200 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2021 | 43 | 0.200 |
Why?
|
| Bacteriophage lambda | 2 | 2010 | 36 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 4549 | 0.190 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 147 | 0.190 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 159 | 0.190 |
Why?
|
| Escherichia coli | 3 | 2011 | 1203 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 327 | 0.180 |
Why?
|
| Saccule and Utricle | 1 | 2019 | 10 | 0.180 |
Why?
|
| Reverse Transcription | 1 | 2019 | 8 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 287 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 315 | 0.160 |
Why?
|
| Gene Amplification | 1 | 2021 | 731 | 0.160 |
Why?
|
| Animals | 10 | 2024 | 59536 | 0.160 |
Why?
|
| Gene Library | 1 | 2019 | 294 | 0.160 |
Why?
|
| Gene Ontology | 1 | 2017 | 80 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2019 | 269 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2017 | 148 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 14551 | 0.150 |
Why?
|
| DNA, Complementary | 1 | 2019 | 869 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 3578 | 0.150 |
Why?
|
| Tamoxifen | 1 | 2021 | 876 | 0.150 |
Why?
|
| Morphogenesis | 1 | 2018 | 337 | 0.150 |
Why?
|
| Aurora Kinases | 1 | 2017 | 189 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 554 | 0.150 |
Why?
|
| Regeneration | 1 | 2019 | 279 | 0.140 |
Why?
|
| Mice | 6 | 2023 | 34495 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 2483 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 345 | 0.130 |
Why?
|
| Pancreas | 1 | 2018 | 718 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2021 | 1026 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1331 | 0.120 |
Why?
|
| Humans | 14 | 2024 | 261506 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2021 | 1818 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2017 | 619 | 0.120 |
Why?
|
| DNA Damage | 1 | 2021 | 1954 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 1489 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 2359 | 0.100 |
Why?
|
| Meiosis | 1 | 2012 | 166 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 1033 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 223 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 1399 | 0.100 |
Why?
|
| Benzamides | 1 | 2017 | 1832 | 0.100 |
Why?
|
| Cochlea | 2 | 2024 | 102 | 0.100 |
Why?
|
| Computational Biology | 1 | 2017 | 1271 | 0.100 |
Why?
|
| Organisms, Genetically Modified | 1 | 2010 | 14 | 0.100 |
Why?
|
| Time | 1 | 2011 | 178 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1491 | 0.100 |
Why?
|
| Bacteriolysis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Genes, Viral | 1 | 2010 | 202 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2012 | 315 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 4113 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 613 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2010 | 200 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 4053 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 1215 | 0.090 |
Why?
|
| Cell Line | 1 | 2017 | 5114 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3230 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2017 | 1471 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 7702 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 3022 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2019 | 3341 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2576 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3154 | 0.060 |
Why?
|
| Neoplasms | 2 | 2020 | 15193 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 361 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2021 | 17 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 3254 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 2021 | 14 | 0.050 |
Why?
|
| Discoidin Domain Receptor 2 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Epithelium | 1 | 2024 | 720 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 4757 | 0.050 |
Why?
|
| Granulocytes | 1 | 2019 | 224 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 100 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 771 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 11538 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 509 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 239 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 475 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 1764 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 6942 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 668 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 114 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2017 | 114 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 671 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 793 | 0.040 |
Why?
|
| Pericytes | 1 | 2017 | 96 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2018 | 1037 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 825 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 328 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 194 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 677 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 250 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 216 | 0.030 |
Why?
|
| Morpholines | 1 | 2017 | 289 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 1130 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 973 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 7222 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 835 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 2450 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 446 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8873 | 0.030 |
Why?
|
| Pyridones | 1 | 2017 | 348 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14289 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 7789 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 494 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 2466 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4143 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 2084 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 51 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 2012 | 56 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 1144 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2012 | 82 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 11965 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2314 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 1498 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 992 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3033 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 295 | 0.030 |
Why?
|
| Stem Cells | 1 | 2018 | 1213 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2012 | 369 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 2809 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2017 | 1048 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 856 | 0.020 |
Why?
|
| Female | 5 | 2019 | 141928 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 1020 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2010 | 121 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6682 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 3570 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3821 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 7226 | 0.020 |
Why?
|
| Male | 4 | 2021 | 123000 | 0.020 |
Why?
|
| Kinetics | 1 | 2011 | 2049 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 829 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2021 | 2947 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 4078 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2232 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7573 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 6150 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 21713 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 77950 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 86204 | 0.000 |
Why?
|